中文 | English
Return
Total: 469 , 1/47
Show Home Prev Next End page: GO
Author:(Xu-Ying XIANG)

1.Randomized, double-blind, parallel-controlled, multicenter, equivalence clinical trial of Jiuwei Xifeng Granules(Os Draconis replaced by Ostreae Concha) for treating tic disorder in children.

Qiu-Han CAI ; Cheng-Liang ZHONG ; Si-Yuan HU ; Xin-Min LI ; Zhi-Chun XU ; Hui CHEN ; Ying HUA ; Jun-Hong WANG ; Ji-Hong TANG ; Bing-Xiang MA ; Xiu-Xia WANG ; Ai-Zhen WANG ; Meng-Qing WANG ; Wei ZHANG ; Chun WANG ; Yi-Qun TENG ; Yi-Hui SHAN ; Sheng-Xuan GUO

China Journal of Chinese Materia Medica 2025;50(6):1699-1705

2.Clinical analysis of 6 cases of diffuse panbronchiolitis in children.

Li-Xin DENG ; De-Hui CHEN ; Yu-Neng LIN ; Shang-Zhi WU ; Jia-Xing XU ; Zhan-Hang HUANG ; Ying-Ying GU ; Jun-Xiang FENG

Chinese Journal of Contemporary Pediatrics 2025;27(3):334-339

4.Photoaffinity probe-enabled discovery of sennoside A reductase in Bifidobacterium pseudocatenulatum.

Yang XU ; Shujing LV ; Xiang LI ; Chuanjia ZHAI ; Yulian SHI ; Xuejiao LI ; Zhiyang FENG ; Gan LUO ; Ying WANG ; Xiaoyan GAO

Journal of Pharmaceutical Analysis 2025;15(1):101108-101108

5.Echocardiographic two-dimensional strain evaluation of right ventricular function in healthy adults

Yi LI ; Ying GUO ; Chenxi XIA ; Xuyang MENG ; Xiang WANG ; Tao XU ; You ZHONG ; Fang WANG

Chinese Journal of Cardiology 2024;52(1):58-63

6.Clinical trial of lanthanum carbonate and calcium carbonate in the treatment of maintenance hemodialysis patients with end-stage renal disease

Xu-Xiang MA ; Han WANG ; Xiao-Ying ZONG ; Yu-Ye ZHOU ; Miao-Miao SANG

The Chinese Journal of Clinical Pharmacology 2024;40(18):2665-2669

7.Structure-based development of potent and selective type-II kinase inhibitors of RIPK1.

Ying QIN ; Dekang LI ; Chunting QI ; Huaijiang XIANG ; Huyan MENG ; Jingli LIU ; Shaoqing ZHOU ; Xinyu GONG ; Ying LI ; Guifang XU ; Rui ZU ; Hang XIE ; Yechun XU ; Gang XU ; Zheng ZHANG ; Shi CHEN ; Lifeng PAN ; Ying LI ; Li TAN

Acta Pharmaceutica Sinica B 2024;14(1):319-334

8.The experience on the construction of the cluster prevention and control system for COVID-19 infection in designated hospitals during the period of "Category B infectious disease treated as Category A"

Wanjie YANG ; Xianduo LIU ; Ximo WANG ; Weiguo XU ; Lei ZHANG ; Qiang FU ; Jiming YANG ; Jing QIAN ; Fuyu ZHANG ; Li TIAN ; Wenlong ZHANG ; Yu ZHANG ; Zheng CHEN ; Shifeng SHAO ; Xiang WANG ; Li GENG ; Yi REN ; Ying WANG ; Lixia SHI ; Zhen WAN ; Yi XIE ; Yuanyuan LIU ; Weili YU ; Jing HAN ; Li LIU ; Huan ZHU ; Zijiang YU ; Hongyang LIU ; Shimei WANG

Chinese Critical Care Medicine 2024;36(2):195-201

9.Application of OSCE-guided Scenario-based Practical Teaching Model in Clinical Pharmacist Training

Tiantian TANG ; Yiwen XIAO ; Haiyan YUAN ; Qiong LU ; Ying WANG ; Wenhui LIU ; Shenglan TAN ; Bikui ZHANG ; Daxiong XIANG ; Yan CHENG ; Yangang ZHOU ; Ping XU

Chinese Journal of Modern Applied Pharmacy 2024;41(10):1409-1414

10.Analysis of epidemiological and clinical characteristics of 1247 cases of infectious diseases of the central nervous system

Jia-Hua ZHAO ; Yu-Ying CEN ; Xiao-Jiao XU ; Fei YANG ; Xing-Wen ZHANG ; Zhao DONG ; Ruo-Zhuo LIU ; De-Hui HUANG ; Rong-Tai CUI ; Xiang-Qing WANG ; Cheng-Lin TIAN ; Xu-Sheng HUANG ; Sheng-Yuan YU ; Jia-Tang ZHANG

Medical Journal of Chinese People's Liberation Army 2024;49(1):43-49

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 469 , 1/47 Show Home Prev Next End page: GO